A predictive model for differentiating hemorrhagic fever with renal syndrome and scrub typhus in southwestern China

This study developed and validated a predictive nomogram model based on five independent factors—male sex, positive proteinuria, elevated creatinine, decreased heart rate, and conjunctival congestion—to effectively differentiate hemorrhagic fever with renal syndrome from scrub typhus in southwestern China.

The Gist

Imagine you are a doctor in a busy clinic in southwestern China. Two patients walk in, both looking very sick. They both have high fevers, headaches, and feel terrible. One has Hemorrhagic Fever with Renal Syndrome (HFRS), and the other has Scrub Typhus (ST).

Here's the problem: These two diseases are like identical twins wearing the same clothes. They are caused by different germs (one by a virus from mice, the other by bacteria from mites), but they look and act so similarly that telling them apart just by looking at the patient is like trying to distinguish between two identical twins in a dark room.

If you guess wrong, you might give the wrong treatment, which could be dangerous. This study is essentially a "Detective's Cheat Sheet" created to help doctors solve this mystery quickly.

The Investigation: How They Solved the Case

The researchers gathered data on 470 patients (235 with HFRS and 235 with ST) from a hospital in Dali. They acted like detectives, looking for tiny clues that would give away the true identity of the disease. They didn't just look at the obvious symptoms; they looked at the "fingerprint" left by the disease in the patient's blood and body.

After sifting through mountains of data, they found five specific clues that were the most reliable "smoking guns" for telling the two diseases apart.

The 5 Clues (The "Magic Ingredients")

Think of these five factors as the ingredients in a special recipe. If a patient has most of these, the doctor can be pretty sure which disease they have.

1. Gender (The "Who" Clue):

   • The Clue: If the patient is Male, it leans toward HFRS.
   • The Analogy: It's like a bouncer at a club. HFRS seems to have a "Men Only" vibe in this region (about 73% of HFRS patients were men), whereas Scrub Typhus is more evenly split or slightly favors women. Men often work in fields or forests where they encounter the mice that carry the HFRS virus.

2. Protein in the Urine (The "Leaky Pipe" Clue):

   • The Clue: If the urine test shows lots of protein, it's likely HFRS.
   • The Analogy: Imagine your kidneys are a coffee filter. In HFRS, the filter gets torn, and the "coffee grounds" (protein) leak right through into the cup (urine). In Scrub Typhus, the filter is usually still holding up better. A positive protein test is a huge red flag for HFRS.

3. Creatinine Levels (The "Kidney Stress" Clue):

   • The Clue: Higher levels of Creatinine (a waste product in the blood) point to HFRS.
   • The Analogy: Think of creatinine as trash piling up in a room. If the trash (waste) is piling up high, it means the "cleaning crew" (the kidneys) is overwhelmed and failing. HFRS hits the kidneys much harder than Scrub Typhus, so the trash pile is bigger.

4. Heart Rate (The "Slow Beat" Clue):

   • The Clue: A slower heart rate suggests HFRS.
   • The Analogy: When you have a fever, your heart usually races like a rabbit. But in HFRS, the virus seems to hit the "brakes" on the heart, making it beat slower than expected for the fever. Scrub Typhus patients usually have a racing heart like a normal fever victim.

5. Red Eyes (The "Conjunctival Congestion" Clue):

   • The Clue: If the whites of the eyes are bright red and bloodshot, it screams HFRS.
   • The Analogy: This is like a car's "check engine" light, but for your eyes. HFRS causes the tiny blood vessels in the eyes to swell and burst like over-inflated balloons, making the eyes look very red. This is much less common in Scrub Typhus.

The "Magic Calculator" (The Nomogram)

The researchers didn't just list these clues; they built a visual calculator called a Nomogram.

• How it works: Imagine a slide rule or a simple app. You plug in the patient's data (Is he a man? Does he have protein in his urine? What's his heart rate?).
• The Result: The calculator slides to a score. If the score is high, the doctor knows, "Okay, this is almost certainly HFRS, let's treat for that." If the score is low, it's likely Scrub Typhus.
• Accuracy: This calculator was 85.6% accurate. That's like a weather forecaster who is right 8 or 9 times out of 10, which is a huge improvement over guessing.

Why Does This Matter?

In the real world, time is life.

• HFRS needs specific supportive care to protect the kidneys.
• Scrub Typhus is treated with a specific antibiotic (Doxycycline).

If a doctor mistakes one for the other, they might delay the right treatment. This study gives doctors in rural areas a simple, fast way to make the right call without waiting for expensive, slow lab tests that might take days to come back.

The Bottom Line

This paper is a victory for early detection. By looking at five simple things—Gender, Protein in urine, Kidney waste levels, Heart speed, and Red eyes—doctors can now tell these two "twin" diseases apart much faster, saving lives and reducing panic in the clinic. It turns a confusing medical mystery into a straightforward checklist.

Technical Summary

1. Problem Statement

Hemorrhagic Fever with Renal Syndrome (HFRS) and Scrub Typhus (ST) are both acute zoonotic infectious diseases prevalent in southwestern China (specifically the Dali region). They share significant overlaps in:

• Epidemiology: Both are associated with rodent vectors and specific seasonal patterns (spring/autumn for HFRS; summer/autumn for ST), leading to concurrent exposure risks.
• Clinical Manifestations: Both present with fever, headache, and systemic symptoms.
• Diagnostic Challenge: Early clinical differentiation is difficult yet critical. Misdiagnosis can lead to delayed treatment, increased mortality, and unnecessary economic burdens. HFRS requires supportive care (no specific antiviral), while ST is treatable with antibiotics (e.g., doxycycline).

The study aims to identify independent predictive factors and construct a clinical model to facilitate the early differentiation between HFRS and ST.

2. Methodology

• Study Design: A retrospective, single-center analysis conducted at the First Affiliated Hospital of Dali University, Yunnan, China.
• Data Period: January 1, 2015 – December 31, 2025.
• Cohort: 470 patients total, comprising 235 laboratory-confirmed HFRS cases and 235 laboratory-confirmed ST cases.
• Inclusion/Exclusion:
  • Inclusion: Patients meeting specific national diagnostic criteria (HFRS: Ministry of Health standards; ST: CDC guidelines).
  • Exclusion: Age <18, comorbidities (malignancy, chronic kidney disease, immunosuppression), or >20% missing clinical data.
• Data Collection: Baseline demographics, vital signs, clinical symptoms, and a comprehensive panel of laboratory indicators (hematology, biochemistry, coagulation, inflammatory markers) collected within 24 hours of admission.
• Statistical Analysis:
  • Univariate Analysis: Used $\chi^2$ or Fisher's exact tests for categorical data; t-tests or Mann-Whitney U tests for continuous data to identify variables with $P < 0.05$.
  • Multivariate Logistic Regression: Variables significant in univariate analysis were entered into a multivariate model to adjust for confounders and identify independent risk factors.
  • Model Construction: A Nomogram was developed based on the independent predictors.
  • Model Evaluation:
    • Discrimination: Measured by the Area Under the Receiver Operating Characteristic Curve (AUC).
    • Calibration: Assessed via calibration curves.
    • Clinical Utility: Evaluated using Decision Curve Analysis (DCA).

3. Key Contributions

1. Identification of Independent Predictors: The study isolated five specific variables that significantly differentiate HFRS from ST after adjusting for confounders:
   • Sex (Male): Strongly associated with HFRS.
   • Positive Proteinuria: A key differentiator favoring HFRS.
   • Creatinine (CREA): Elevated levels indicate renal injury typical of HFRS.
   • Heart Rate: Lower heart rates (bradycardia) are associated with HFRS.
   • Conjunctival Congestion: Highly prevalent in HFRS compared to ST.
2. Development of a Nomogram: The authors created a visual predictive tool (Nomogram) incorporating these five variables, allowing clinicians to calculate the probability of a patient having HFRS vs. ST at the bedside.
3. First of its Kind: This is the first study to develop a specific nomogram model for the early differentiation of these two diseases in the Dali region.

4. Results

• Demographics & Epidemiology:
  • HFRS: Bimodal seasonal distribution (peaks in spring and autumn). Predominantly male (2.67:1 ratio), rural farmers/forestry workers.
  • ST: Unimodal distribution (peaks in summer and autumn). Predominantly female (1:1.45 ratio).
• Multivariate Analysis Findings:
  The multivariate logistic regression identified the following independent risk factors for HFRS (vs. ST):
  • Male Sex: ajOR = 2.093 (95% CI: 1.107–3.957).
  • Positive Proteinuria: ajOR = 4.937 (95% CI: 2.427–10.042).
  • Creatinine (CREA): ajOR = 1.009 per unit increase (95% CI: 1.003–1.015).
  • Heart Rate: ajOR = 0.981 per beat/min (95% CI: 0.966–0.997). Note: Lower heart rate increases the probability of HFRS.
  • Conjunctival Congestion: ajOR = 16.167 (95% CI: 5.326–49.072).
• Model Performance:
  • AUC: The model achieved an AUC of 0.856, indicating good discriminatory power.
  • Calibration: The calibration curve showed strong agreement between predicted probabilities and actual observed outcomes.
  • Decision Curve Analysis (DCA): The model demonstrated high clinical net benefit across a threshold probability range of 10% to 95%, suggesting it is superior to "treat all" or "treat none" strategies.

5. Significance and Limitations

Significance:

• Clinical Utility: The model provides a rapid, non-invasive, and cost-effective tool for primary care physicians in endemic areas to distinguish between HFRS and ST before confirmatory serological or PCR results are available.
• Treatment Optimization: Early differentiation ensures timely administration of antibiotics for ST (preventing organ failure) and appropriate supportive care for HFRS, potentially reducing mortality and resource waste.
• Pathophysiological Insight: The findings reinforce the distinct pathophysiology: HFRS is characterized by severe renal microvascular damage (proteinuria, high creatinine, bradycardia) and conjunctival hyperemia, whereas ST presents with different systemic vascular involvement.

Limitations:

• Single-Center: Data was derived from one hospital, potentially limiting generalizability to other regions with different genetic or environmental factors.
• Sample Size: While 470 patients is substantial, the sample size for multivariate analysis could be larger to increase statistical power.
• Lack of Validation: The study lacked internal (bootstrapping) and external (multi-center) validation cohorts.
• Missing Advanced Markers: The study could not include specific viral genotypes, troponin, or quantitative urine protein due to their non-routine status in the clinical setting at the time of data collection.

Conclusion:
The study successfully developed a robust predictive nomogram using five readily available clinical variables (Sex, Proteinuria, Creatinine, Heart Rate, Conjunctival Congestion). This tool offers a practical solution for the early differential diagnosis of HFRS and ST in southwestern China, aiding in timely clinical decision-making.